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iabetes mellitus (DM) is one of the most 
common health problems in the com-
munity. DM is associated with pathologic 
changes in the cardiovascular system due to alterations in 
the autonomic nervous system (ANS). Dysfunction of the 
cardiovascular ANS can lead to fatal arrhythmias and sud-
den death. The aim of this study was to investigate the re-
lationship between changes in heart rate variability (HRV) 
indices and blood glucose control status in patients with 
type 2 DM. Patients with type 2 DM who presented to 
our university Diabetes Clinic were eligible to be included. 
Fasting blood glucose (FBG), 2-hour postprandial blood 
glucose test (2PPG), and hemoglobin A1C (HbA1C) were 
measured. According to the HbA1C the patients were 
categorized as euglycemia (HbA1C <7%) and poorly con-
trolled DM (HbA1C >7%). HRV indices were determined 
by 24-hour Holter monitoring. There were 41 patients 
with euglycemia and 39 patients whose blood glucose 
was poorly controlled. pNN, SDANN, and SDNN indices 
were significantly higher in the euglycemia group than 
in the group with poorly controlled glucose. There was 
significant and inverse correlation between pNN, SDANN, 
and SDNN with serum levels of HBA1C. However, no sig-
nificant correlation was observed between FBS and 2PPG 
with HRV indices. HRV indices were significantly lower 
in diabetic patients with poorly controlled blood glucose 
when compared to diabetics with good control of blood 
glucose. These findings reflect dysfunction of the ANS in 
patents with poorly controlled blood glucose.
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a diabetes mellitus (DM) es uno de los proble-
mas de salud más comunes en la comunidad. 
La DM se asocia con cambios patológicos en 
el sistema cardiovascular debido a alteraciones en el sis-
tema nervioso autónomo (SNA). La disfunción de la ANS 
cardiovascular puede llevar a arritmias fatales y muerte 
súbita. El objetivo de este estudio fue investigar la rela-
ción entre los cambios en los índices de variabilidad de 
la frecuencia cardíaca (HRV) y el estado de control de la 
glucosa en sangre en pacientes con DM tipo 2. Los pa-
cientes con DM tipo 2 que acudieron a nuestra Clínica de 
Diabetes de la universidad fueron elegibles para ser inclui-
dos. Se midieron la glucemia en ayunas (FBG), la prueba 
posprandial de glucosa en sangre durante 2 horas (2PPG) 
y la hemoglobina A1C (HbA1C). Según la HbA1C, los pa-
cientes se clasificaron como euglucemia (HbA1C <7%) y 
DM mal controlada (HbA1C>7%). Los índices de HRV se 
determinaron mediante un monitoreo Holter de 24 horas. 
Hubo 41 pacientes con euglucemia y 39 pacientes cuya 
glucemia estaba mal controlada. Los índices pNN, SDANN 
y SDNN fueron significativamente más altos en el grupo 
con euglucemia que en el grupo con glucosa mal con-
trolada. Hubo una correlación significativa e inversa entre 
pNN, SDANN y SDNN con los niveles séricos de HBA1C. 
Sin embargo, no se observó una correlación significativa 
entre FBS y 2PPG con índices HRV. Los índices de HRV 
fueron significativamente más bajos en los pacientes dia-
béticos con glucemia mal controlada en comparación con 
los diabéticos con buen control de la glucemia. Estos ha-
llazgos reflejan una disfunción de la ANS en las patentes 
con glucosa en sangre mal controlada.
Palabras clave: Diabetes mellitus; Sistema nervioso au-
tónomo; variabilidad de la frecuencia cardíaca (VFC); he-
moglobina a1c.
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iabetes mellitus (DM) comprises a group 
of common metabolic disorders that 
share hyperglycemia in their phenotype1. 
The metabolic imbalances seen in DM can result in patho-
physiologic changes in several parts of the body. These 
changes are responsible for most morbid states seen in 
diabetics in a way that DM is known as the leading cause 
of end-stage renal disease (ESRD), non-traumatic amputa-
tions of the lower extremities, cardiovascular diseases and 
blindness in adults2. As the prevalence of DM is increas-
ing worldwide, DM will continue to be a major cause for 
morbidity and mortality. 
Diabetic neuropathy is seen in about 50% of people with 
long-term types 1 and 2 DM. This disorder can manifest as 
polyneuropathy, mononeuropathy, or autonomic neurop-
athy. DM-related autonomic neuropathy can affect several 
organs including cardiovascular, digestive, genitourinary 
systems. Autonomic neuropathy that affects the cardio-
vascular system causes tachycardia at rest and orthostatic 
hypotension3. Autonomic neuropathy may be due to the 
involvement of the sinus node regulation which results in 
decreased heart-rate variability (HRV). The decreased HRV 
can predispose the patient to fatal arrhythmias. Autonom-
ic neuropathy, characterized by a massive neurological 
degeneration, affects the small neural fibers of the sym-
pathetic and parasympathetic divisions of the autonomic 
nervous system (ANS)4.
DM, as a metabolic derangement, is associated with car-
diovascular changes as a result of changes in the ANS. 
Dysfunction of the cardiovascular ANS among diabetics 
can cause fatal arrhythmias and sudden cardiac death5. 
Cardiovascular diseases are one of the most common 
diseases, and heart failure today is considered to be the 
major cause of mortality in industrial and semi-industrial 
societies. For this reason, identification of disorders in the 
cardiovascular system of patients with DM has an impor-
tant role in the prevention of disability and morbidity and 
mortality consequences from cardiovascular conditions.
A reliable method to investigate the cardiovascular ANS 
function is the analysis of HRV (heart rate variations with 
intervals between successive heartbeats)6. The intervals 
between the QRS complexes known as NN (normal to 
normal) or RR (R to R) intervals are reference indices to 
investigate HRV. Although there are several non-invasive 
methods for investigating ANS function, HRV analysis is 
a simple and reliable method for evaluating sympathova-
gal balance at the sino-atrial (SA) node level. Given the 
benefits of HRV analysis, this method has been used in 
many disorders including diabetic neuropathy, myocardial 
infarction (MI) and heart failure7. Previous studies have 
shown that in one-third of diabetics, some degrees of ear-
ly stages of autonomic neuropathy, which can be evalu-
ated with HRV analysis, have been documented prior to 
development of clinical symptoms4.
The severity of ANS dysfunction in DM correlates with 
severity and duration of DM. the autonomic disorders of 
diabetes is related to the severity and duration of the dis-
ease. Although several studies have been conducted on 
the state of glucose control in diabetic patients and its 
association with ANS dysfunction, contradictory findings 
have been noted. Therefore, further studies are required. 
Hence, in this study, we examined the relationship be-
tween changes in HRV indices and the status of blood 
glucose control in diabetic patients.
n this study, 80 patients with type 2 DM who pre-
sented to the Diabetes Clinic of our medical univer-
sity were included. Exclusion criteria were the pres-
ence of other underlying conditions (such as malignancy), 
congenital cardiovascular disorders, major thalassemia, 
and history of myocardial infarction, heart failure, and ar-
rhythmia. 
To evaluate the patients’ blood glucose control, fasting 
blood glucose (FBG), 2-hour postprandial blood glucose 
test (2PPG), and serum hemoglobin A1C (HbA1C) levels. 
A serum HbA1C level less than 7 mg/dL was considered as 
controlled blood glucose and euglycemia8.  
The patients were selected from those that had under-
gone 24-hour Holter monitoring at the Diabetes Clinic 
during the preceding two years. The patients were divided 
into two groups. One group consisted of patients with 
euglycemia (HbA1C <7%) and the other group consisted 
of diabetics with poorly controlled blood glucose level 
(HbA1C >7%). 
The patients underwent Holter monitoring (PADSY.5.2A, 
Germany) to determine HRV indices. The analysis of HRV 
indices were done based on time intervals. The analysis of 
time intervals included pNN50, SDNN, and SDANN which 
indicate QRS complexes in 55 msec intervals. Then, the 
obtained data were compared with baseline indices and 
the changes were analyzed. The gathered data were en-
tered into a checklist.  
Statistical analyses
The continuous variables were analyzed and compared 
between the two groups by the Mann-Whitney U test. 
The categorical variables were compared between the 
two study groups by the Chi-squared test. The correla-
tion between the continuous variables was analyzed by 
the Spearman test. A P value of less than 5% was consid-
ered statistically significant. The statistical analyzes were 
























A total number of 80 patients were included. There were 
41 patients in euglycemia group and 39 patients in poorly 
controlled blood glucose level. In euglycemia group, there 
were 17 male and 24 female patients. In diabetic patients 
whose blood glucose levels were poorly controlled, there 
were 16 male and 23 female patients. The gender dis-
tribution was comparable between the two groups (P= 
0.968); Table 1.
Mean (±SD) DM duration in euglycemia and poorly con-
trolled glucose groups were respectively 8.7 (±4.2) and 
9.2 (±5.6) years. As seen in Table 1, no difference was ob-
served between the two study groups regarding age, gen-
der distribution, DM duration, and blood pressure (systolic 
and diastolic). On the other hand, FBG, HbA1C, and 2PPG 
were significantly higher in poorly controlled blood glu-
cose level compared to euglycemia group.







Age, year 52 (±9.2) 54 (±8.7) 0.233
Gender, male 16 17 0.968
Diabetes mellitus 
duration, year
9.2 (±5.6) 8.7 (±4.6) 0.306
SBP, mmHg 140 (±25) 139 (±18) 0.884
DBP, mmHg 81 (±13) 80 (±7) 0.541
FBG, mg/dL 177 (±71) 128 (±27)
< 
0.001





255 (±81) 190 (±43)
< 
0.001
FBG= fasting blood glucose; SBP= systolic blood pressure; 
DBP= diastolic blood pressure
Mean (±SD) primary and secondary SDANN difference 
time (ΔSDANN) in euglycemia group (13± -1) was not dif-
ferent from poorly controlled glucose group (17± -3); P= 
0.946 (Table 2).  
Table 2. The difference between primary and secondary 
measurements of heart-rate variability indices and their 





ΔSDNN 18 (±4) 21 (±4) 0.373
ΔSDANN 17 (± -3.4) 13 (± -1) 0.946
ΔPNN 1.5 (±0.19) 2.3 (± -0.8) 0.167
There was significant inverse correlation between se-
rum HbA1C and HRV indices including PNN, SDNN, and 
SDANN. These indices were lower in those with poor con-
trolled blood glucose and higher HbA1C level. However, 
no significant association was found between FBG and 
2PPG with HRV indices (Table 3). 
Table 3. The correlation between fasting blood glucose 
(FBG), 2-hour postprandial glucose (2PPG), and HbA1c kevel 
with heart-rate variability (HRV) indices
HbA1C, % FBG, mg/dL 2PPG, mg/dL
P value r P value r P value r
SDNN1 0.001 - 0.366 0.087 - 0.192 0.022 - 0.257
SDNN2 0.001 - 0.364 0.118 - 0.176 0.018 - 0.265
SADNN1 0.002 - 0.341 0.207 - 0.143 0.108 - 0.181
SADNN2 0.003 - 0.332 0.275 - 0.124 0.088 - 0.192
PNN1 0.013 - 0.277 0.832 - 0.024 0.751 - 0.036
PNN2 0.005 - 0.313 0.095 - 0.188 0.272 - 0.124
he aim of this study was to determine the rela-
tionship between changes in HRV indices and 
blood glucose control status in patients with 
type 2 DM. Several studies have been done to investigate 
the status of blood glucose control in diabetics and its 
association with ANS dysfunction. Despite controversies, 
all studies indicate that the severity of ANS dysfunction 
correlates with severity of DM and its duration. In our 
study, which was performed on patients with type 2 DM, 
it was found that HRV indices were significantly lower 
among those with poorly controlled blood glucose when 
compared to the other group with euglycemia. This de-
creased state of HRV indices reflects impairment of the 
cardiovascular ANS, was observed over two year period 
of follow-up. Although the HRV indices were significantly 
lower in patients with poorly controlled blood glucose 
than in euglycemia group, the decrease over the follow-
up period was not statistically significant. It seems that 
the severity of cardiovascular ANS dysfunction was more 
severe in more prolonged DM and since our follow-up 
was relatively short (two years), the difference did not be-
came significant. 
In a study by Faulkner et al. on patients with types 1 and 
2 DM, it was reported that cardiovascular stability was 
poorer in patients with higher body mass index (BMI), 
poorer control of blood glucose, and less physical activity. 
It was also reported that HRV in type 2 DM group was 
lower than in type 1 DM9, which is consistent with the 
results of this study. In another study by Faulkner et al. in-
cluding healthy subjects and patients with type 1 DM, RR 
changes were less prominent in diabetics than in healthy 
subjects. Also, an inverse correlation was detected be-
tween serum HbA1C level and sympathetic balance in 
diabetics10, which is comparable to our findings. 
Chen et al. in their study involving 79 patients with type 
1 DM showed that HbA1C level and duration of DM had 
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there was only a meaningful relationship between serum 
HbA1c and HRV indices. This can be justified as all pa-
tients with DM included had type 2 DM with lower dura-
tion of the disease. But in other studies, mostly type 1 
DM patients had been studied. In a separate study by Eller 
on 74 patients, serum HbA1C level and waist-hip ratio 
had significant inverse correlation with HRV indices12. The 
results reported by Richard et al. on 88 patients showed 
that significant decrease in ANS function which had direct 
relationship with serum HbA1C level and age13, which is 
in agreement with our findings.   
There are several studies which contradict the obtained 
findings. For example, in a large study of 684 patients 
with type 1 DM, cardiovascular autonomic neuropathy 
had significant correlation with decreased low frequency 
(LF) and high frequency (HF) in HRV. In addition, obesity 
and serum HbA1C level did not show correlation with the 
severity of cardiovascular autonomic neuropathy14. Kho-
haro et al. studied type 1 DM patients and reported that 
HRV had a significant inverse correlation with the duration 
of the disease, while there was no correlation with the 
blood glucose control status of the patients15. In studies 
conducted by Hsu et al. on diabetic patients who had un-
dergone NCV (nerve conduction velocity) and HRV inves-
tigations, age, renal function impairment, HbA1C level, 
and FBG had correlation with somatic neuropathy, while 
only systolic blood pressure had correlation with auto-
nomic neuropathy16-18. 
In conclusion, in patients with poor control of blood glu-
cose status, HRV indices were significantly lower compared 
to those with euglycemic state. This condition which re-
flects cardiovascular AND dysfunction remained after two 
years of follow-up of the patients17. Serum HbA1C level 
had a significant inverse correlation with HRV indices. Dis-
turbance in cardiovascular ANS and its relationship with 
the state of blood glucose control can propose conduc-
tion of further studies to explore the required interven-
tions to decrease the related complications.
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